Cardinal Health Inc. closed 4.21% short of its 52-week high of $153.74, which the company achieved on May 7th.

What CEO Jason Hollar has to say about Cardinal Health's stock closing at all-time highs for three consecutive days.

We recently published a list of Billionaire Mason Hawkins’ 10 Mid-Cap Stocks with Huge Upside Potential. In this article, we ...

Q3 2025 Earnings Call Transcript May 1, 2025 Cardinal Health, Inc. beats earnings expectations. Reported EPS is $2.35, ...

Cardinal Health Inc. (NYSE:CAH) on Thursday reported third-quarter 2025 adjusted EPS of $2.35, up 13% year over year, beating ...

Executives said Thursday that the company has already laid off employees to help mitigate the effects of the Trump ...

Cardinal Health’s Mike Brown, vice president of managed services, and Michelle Dalton, regional director of account ...

Cardinal Health recently approved an increase in its quarterly dividend, a move that aligns with the company's notable 21% price increase last quarter. This uptick came despite a general market ...

Drug distributor Cardinal Health on Thursday raised its fiscal 2025 adjusted profit forecast for the fourth time, betting on strong demand for costly specialty medicines and branded drugs.

DUBLIN, Ohio, May 7, 2025 /PRNewswire/ -- Today, Cardinal Health (NYSE: CAH) released its 2025 Advanced Therapies Report: Revolutionizing patient care – the promise and potential of cell and ...

Cardinal Health has reported revenues of $54.9 billion for the third quarter fiscal year 2025, flat to the same period last ...

Non-GAAP net earnings attributable to Cardinal Health, Inc.: net earnings attributable to Cardinal Health, Inc. excluding (1) LIFO charges/(credits), (2) state opioid assessment related to prior ...